Improving Childhood Obesity-Related Behavior Change Through Better Risk

Status Not yet recruiting

Clinical Trial Summary

One-third of American children are overweight or obese, leading to an increased risk for cardiovascular disease (CVD), early mortality, and other risks throughout their lifespan relative to normal weight children. In our pilot work, we found that 67-83% of parents underestimate a child's long-term risk of developing cardiovascular disease in adulthood and that parents thought their own child's risks were 13-15% lower than those of a typical child in their community, even controlling for family health and demographic characteristics. Parents were 40 times less likely to predict that their child, rather than a typical child in their community, would be overweight or obese in adulthood. These findings suggest that parents suffer from optimism bias, the tendency to overestimate one's chances of experiencing unlikely positive events. Belief that a child is at increased risk for adverse health outcomes in adulthood could be an important motivator for a family to initiate behavior changes and vice versa.

The overall goal of this research is to develop provider-based risk communication approaches to motivate parents of obese children to engage in behavior change to protect their children from CVD and other obesity-related co-morbidities later in life. Specifically, the investigators will:

1. Develop risk communication methods that providers can use to better convey accurate information about a child's health behaviors, obesity status, and future health risks to parents.

2. Using an online experiment, we will evaluate the impact of new risk communication methods on parental engagement in behavior change.

3. Pilot test the feasibility, acceptability, and impact of new risk communication approaches in pediatric primary care clinics.

This work will give pediatricians novel tools to effectively discuss the long-term consequences of childhood obesity with parents. The findings from this work will inform an interventional trial that will assess the impact of improved risk communication techniques on child behavior change and health outcomes.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03074929
Study type	Interventional
Source	Seattle Children's Hospital
Contact	Davene R Wright, PhD
Phone	206-884-8241
Email	davene.wright@seattlechildrens.org
Status	Not yet recruiting
Phase	N/A
Start date	November 1, 2017
Completion date	September 1, 2020

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT03994419` - PErioperAtive CHildhood ObesitY
Active, not recruiting	`NCT06259539` - A YouTube Curriculum for Children With Autism and Obesity	N/A
Completed	`NCT03533621` - Gut Microbiome, Adiposity, and Probiotics (GMAP)	N/A
Completed	`NCT03641521` - A Trial to Increase Child Vegetable Intake Through Behavioral Strategies	N/A
Completed	`NCT04009304` - Effective Training Models for Implementing Health-Promoting Practices Afterschool	N/A
Completed	`NCT05563311` - Functional Assessment and Sleep Apnea in Obese Children and Adolescents	N/A
Terminated	`NCT03586544` - Reducing Exercise-induced Bronchoconstriction in Children With Asthma and Obesity	Phase 4
Completed	`NCT03575884` - Fit 5 Kids Screen Time Reduction Curriculum for Latino Preschoolers	N/A
Completed	`NCT04628897` - Physical Activity and the Home Environment in Preschool-aged Children in Urban Bangladesh
Completed	`NCT03399617` - SPOON: Sustained Program for Improving Nutrition - Guatemala	N/A
Enrolling by invitation	`NCT06265597` - The Effect of Healthy Nutrition and Yoga Program on Obese Children	N/A
Active, not recruiting	`NCT03843424` - Treatment Efforts Addressing Child Weight Management by Unifying Patients, Parents & Providers	N/A
Completed	`NCT03170700` - Online Videos and New Feeding Content to Enhance a Current EFNEP Program	N/A
Not yet recruiting	`NCT06464497` - Whole Foods for Teens: A Pilot Dietary Intervention to Reduce Body Adiposity in Adolescents With Obesity	N/A
Enrolling by invitation	`NCT05551650` - El Sendero: Pathways to Health Study
Completed	`NCT04346433` - Sleep and Stigma: Novel Moderators in the Relationship Between Weight Status and Cognitive Function	N/A
Recruiting	`NCT03963557` - Cognitive Function and Body Mass Index in Children and Adolescents
Completed	`NCT03495310` - Effect of Mindfulness on Stress, Appetite Hormones and Body Weight of Obese Schoolchildren. Controlled Clinical Trial	N/A
Recruiting	`NCT06028113` - A Novel Obesity Prevention Program for High-Risk Infants in Primary Care	Phase 2
Active, not recruiting	`NCT05465057` - "HIIT Med Kiloene".	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Improving Childhood Obesity-Related Behavior Change Through Better Risk Communication

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms